Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality - The STATUETTE Cohort Study.
Mathias DamkjærCharlotte Suppli UlrikNina Skavlan GodtfredsenKjell Erik Julius HåkanssonPublished in: International journal of chronic obstructive pulmonary disease (2021)
We found an association between beta blocker use and all-cause mortality in high-risk COPD outpatients. No association was found between beta blocker use and risk of AECOPD.